Nova Ljubljanska Banka D D Ljubljana — Issuance of notes

NLB is issuing €350 million in AT1 notes at 7.40% to boost regulatory capital.

What the company is saying

NOVA LJUBLJANSKA BANKA D.D., LJUBLJANA (NLB) is announcing the issuance of €350 million in Additional Tier 1 notes, with a focus on strengthening its regulatory capital base. The company frames the offering as a technical capital instrument, emphasizing the structural terms: a 7.40% coupon until November 2031, no fixed maturity, and a first call date five years after issuance. The announcement highlights that the notes are intended to qualify as AT1 capital and are being placed with eligible counterparties and professional clients outside the US. NLB explicitly states that the notes are high-cost funding and may affect future earnings, acknowledging the trade-off between capital strength and funding expense. The tone is factual and neutral, with no promotional language or forward projections beyond the regulatory intent. No executives are named, and no allocation or demand figures are disclosed.

What the data suggests

The disclosed figures show a €350 million issuance of perpetual Additional Tier 1 notes, priced at 100.00% of nominal value, with a 7.40% coupon until November 2031. After that, the coupon resets every five years, but the new rate is not specified. The notes are callable at the issuer's option from November 2031 and on each subsequent interest payment date. The issuer retains the right to cancel interest payments, a standard AT1 feature. The instrument is intended to qualify as regulatory capital, but there is no disclosure of current or pro forma capital ratios, nor any quantification of the expected impact on earnings. The announcement is complete regarding structural terms but omits any analysis of how the high coupon will affect net interest margin or profitability. No information is provided on investor allocation, demand, or listing venue. The facts support the claim of a capital-raising event but do not allow assessment of the net benefit or cost to shareholders.

Analysis

The announcement is a factual disclosure of a forthcoming EUR 350 million AT1 note issuance, with all key structural terms (amount, coupon, call dates, ISIN) clearly stated. The only forward-looking claims are procedural (the notes 'will be issued' on a specified date) and a generic statement that the issuance 'should strengthen regulatory capital while adding a high-cost funding item that may affect future earnings.' There is no promotional or exaggerated language; the tone is neutral and technical. No specific projections, targets, or aspirational claims are made about financial performance, and no attempt is made to overstate the benefits. The capital outlay is large, but this is inherent to the nature of a capital instrument issuance, and the immediate effect is regulatory capital enhancement. The gap between narrative and evidence is minimal, as all claims are either structural features or standard regulatory intent.

Risk flags

• ●The 7.40% coupon represents a high cost of funding, which will put pressure on net interest margins and could negatively affect future earnings, especially if the bank cannot offset this with higher-yielding assets.
• ●The issuer has discretion to cancel interest payments, which is a standard AT1 feature but introduces risk for noteholders and could impact market perception of the bank's financial strength if exercised.
• ●No quantitative disclosure is provided on the pro forma impact to regulatory capital ratios or earnings, leaving investors unable to assess whether the capital raised meaningfully improves solvency or simply adds expensive leverage.

Bottom line

NLB's €350 million AT1 note issuance delivers an immediate boost to regulatory capital, but the 7.40% coupon locks in a high funding cost that could weigh on future earnings. The structural terms are fully disclosed, but the absence of data on capital ratios, allocation, or projected earnings impact limits visibility into the net benefit for shareholders. Investors should recognize that while regulatory capital is strengthened, the cost of this capital is significant and may dilute returns. The lack of detail on investor demand or pricing relative to market conditions leaves open questions about the market's appetite for NLB's risk profile. The most important takeaway is that this is a technical capital-raising move with clear costs and only implied benefits, not a transformative event for the bank's financial trajectory.

Announcement summary

(LSE:NLB) NOVA LJUBLJANSKA BANKA D.D., LJUBLJANA (NLB) will issue EUR 350 million of Additional Tier 1 notes on 17 November 2026. The notes have no fixed maturity and are callable at the issuer's option from 17 November 2031 and on each subsequent interest payment date. Interest on the notes accrues at 7.40% per annum until 17 November 2031. After 17 November 2031, the interest rate will reset every five years. The issuer may cancel interest payments at its discretion. The issue price is 100.00% of nominal value. The ISIN for the notes is XS3565258764. The notes are being placed with eligible counterparties and professional clients outside the US. The notes are intended to qualify as AT1 capital. This issuance is expected to strengthen NLB's regulatory capital position. The notes will add a high-cost funding item that may affect future earnings. The notes are Additional Tier 1 instruments, which are a form of regulatory capital. The placement is not available to US persons. The notes are callable at the issuer's option from 17 November 2031 and on each subsequent interest payment date.

Disagree with this article?